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CASE REPORT
Optical coherence tomography 
angiography findings of choroidal 
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Abstract 
Angioid streaks (AS) are the most common ocular manifestation in patients with pseudoxanthoma elasticum (PXE). 
The major cause of severe visual loss in patients with AS is choroidal neovascularization (CNV). We report the optical 
coherence tomography angiography (OCTA) findings of CNV in a patient with PXE and angioid streaks. A 51‑year‑old 
man with PXE presented with visual disturbance in his right eye. Best corrected visual acuity was 20/30 OD and 20/30 
OS. Funduscopic examination revealed angioid streaks and type 1 NV in his right eye. Multimodal imaging including 
OCTA demonstrated CNV nasal to the fovea. The morphology and configuration of CNV followed the path of the AS. 
OCTA combined with other multimodal imaging modalities may be a useful tool for diagnosing CNV secondary to 
angioid streaks in patients with pseudoxanthoma elasticum. The configuration of CNV in these may follow the path of 
angioid streaks implicating Bruch’s membrane disruption as an important anatomical change in the pathogenesis of 
CNV.
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Background
Pseudoxanthoma elasticum (PXE) is a rare inherited mul-
tisystem disorder. There are many ocular manifestations 
associated with PXE of which angioid streaks (AS) are 
the most common. AS represent breaks within calcified 
and thickened elastic fibers of Bruch’s membrane. They 
often do not affect visual function, but they may be com-
plicated by the development of choroidal neovasculariza-
tion (CNV), which is a major cause of visual loss in these 
patients. Optical coherence tomography angiography 
(OCTA) is relatively new non-invasive imaging modal-
ity that demonstrates flow-characteristics of the vascular 
network. In this report we demonstrate the morphology 
and spatial relationships of CNV and angioid streaks 
using OCTA.
Case presentation
Pseudoxanthoma elasticum is an inherited multisystem 
disorder with a prevalence range between 1:25,000 and 
1:100,000 [1]. There are many ocular manifestations asso-
ciated with PXE of which angioid streaks (AS) are the 
most common. Angioid streaks are identified in approxi-
mately 85% of eyes with PXE and represent breaks within 
calcified and thickened elastic fibers of Bruch’s mem-
brane [2, 3]. AS often do not affect visual function, even 
if they cross into the foveal area, but they may be com-
plicated by the development of choroidal neovasculariza-
tion (CNV) [4]. The occurrence of CNV is a major cause 
of visual loss in PXE and our knowledge concerning the 
pathogenesis, morphology and natural course of this 
complication remains limited [5].
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Optical coherence tomography angiography (OCTA) 
is relatively new imaging modality that exploits flow-
characteristics within the regional circulation to con-
struct non-invasive images of the vascular network 
[6]. En face images generated by OCTA also allows us 
to study the spatial relationships between vasculature 
and adjacent retinal/choroidal layers with greater pre-
cision than dye angiography. In this report, we inte-
grate OCTA with other multimodal imaging findings 
to improve our understanding of CNV in the setting of 
angioid streaks.
The  study was approved by the  Western Institutional 
Review Board and written informed consent was pro-
vided by the patient. A 51-year-old male patient had 
received care for the ocular complications of pseudoxan-
thoma elasticum for 9 years. Best corrected visual acuity 
was 20/30 OD and 20/30 OS. On presentation, his right 
eye demonstrated AS on multimodal imaging (Fig.  1). 
Color fundus and red-free photographs revealed the 
AS in the peripapillary area radiating to the periphery 
of the posterior pole and towards the fovea with slight 
foveal mottling. Fluorescein angiography showed variable 
Fig. 1 Multimodal imaging findings of angioid streaks at baseline visit. Color (a) and red‑free (RF) photographs (b) of the right eye show angioid 
streaks at the peripapillary region radiating into the fovea. Late‑phase fluorescein angiogram (c; FA) shows variable staining of the angioid streaks 
with no leakage. Fundus autofluorescence (d; FAF) imaging shows areas of hypoautofluorescence in the peripapillary area that are greater in size 
than the corresponding AS seen on color photography. AS correlate to breaks within the Bruch’s membrane (yellow arrow) as seen on spectral 
domain optical coherence tomography (e; SD‑OCT). The yellow line indicates the location of the SD‑OCT scan.
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staining of the AS without leakage in any phase. Fundus 
autofluorescence showed distinct areas of hypoauto-
fluorescence corresponding to the AS with focal spots of 
increased autofluorescence alongside the AS. SD-OCT 
showed breaks in Bruch’s membrane (BrM) with preser-
vation of the overlying RPE. His left eye showed subfo-
veal CNV that was treated with photodynamic therapy 
(PDT) and several anti-vascular endothelial growth 
Fig. 2 Multimodal imaging findings of choroidal neovascularization. Angioid streaks are observed on the red‑free image (a); however, no hemor‑
rhage is evident. Overlay of false‑colored optical coherence tomography angiography (OCTA) over the color photograph (b) outlines the area of 
choroidal neovascularization (CNV). En Face OCTA (c) demonstrates two area of CNV (red and blue arrows) that demonstrate a tangled morphology 
of vascular networks. Sites of CNV closely correlate to sites of angioid streaks (d; arrowheads) when OCTA is compared to en face reflectance images. 
Structural OCT scans (I and II) confirm a mixed type 1 (I) and type 2 (II) neovascular lesion which arise in proximity to sites of Bruch’s membrane 
disruption.
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factor (anti-VEGF) injections with eventual subretinal 
fibrosis. Final best corrected visual acuity in the left eye 
was 20/30.
Five years later, the patient presented with visual distur-
bances involving his right eye. Dilated funduscopic exam-
ination revealed juxtafoveal CNV. The patient underwent 
monthly injections of bevacizumab (1.25 mg/0.05 ml) for 
11 months that achieved regression of the lesion.
Two years following this, there was recurrence of CNV 
in the same eye. Multimodal imaging characteristics of 
this CNV are provided in Figs. 2 and 3. There was no evo-
lution in the size of the angioid streaks since presenta-
tion. OCTA demonstrated CNV nasal to the fovea. The 
morphology of CNV was characterized by a tangled net-
work of vessels [7]. The configuration of CNV closely fol-
lowed the trajectory of AS. Structural OCT revealed type 
1(between RPE and BrM) and type 2 (sub-retinal) neo-
vascularization. Breaks in BrM were seen on the outer 
aspect of the area of neovascularization. Visualization of 
the ultrastructural features of CNV using indocyanine 
green angiography was limited in this case due to the 
hyperfluorescence of angioid streaks at the site of CNV.
The patient received monthly intravitreal ranibizumab 
(0.5 mg/0.05 ml) injections on a pro re nata protocol for 
2 months. The CNV was quiescent for 5 months. On his 
last visit date his best corrected visual acuity was 20/25 
OD 20/30 OS.
Choroidal neovascularization (CNV) is an impor-
tant cause of vision loss in eyes with angioid streaks and 
occurs in approximately 42–84% of cases. While type 2 
NV is the most common presenting anatomical subtype 
of NV to occur in the setting of angioid streaks, type 1 
and mixed (type 1 and type 2) lesions occur in up to 16% 
of eyes [8]. Bruch’s membrane (BrM) plays a critical role 
in retinal and choroidal physiology and regulates nutri-
ent exchange and metabolic homeostasis [9]. BrM also 
serves an important mechanical function and separates 
the choroidal circulation from the outer retina. Inter-
ruptions in the mechanical integrity of BrM can result 
in dysregulation of regional growth factor gradients that 
together with a potential communication between reti-
nal and choroidal compartments can culminate in CNV. 
Focal defects in BrM have been implicated in the patho-
physiology of CNV in a range of conditions; however, 
this relationship is best exemplified in conditions with 
angioid streaks. The spatial relationship between Bruch’s 
membrane and CNV can be precisely studied using 
OCTA where, as shown in this report, there is a close 
relationship between the morphology of BrM defects and 
the topographic pattern of CNV. The morphology of type 
1 NV, with respect to the tangled morphology of patho-
logical vessels, [10] shows many similarities to what has 
been described in AMD. This suggests that there is some 
overlap in biochemical stimuli that promote pathologi-
cal angiogenesis in AMD and conditions associated with 
angioid streaks.
Conclusions
The multimodal imaging characteristics of angioid 
streaks have been previously reported [8, 11–13]. To 
our knowledge, this is the first report to demonstrate 
the morphology and spatial relationships of CNV and 
angioid streaks using OCTA. Our observations support 
the evidence that breaks in BrM are indeed the under-
lying pathology of AS [11]. The findings in this report 
implicate a critical role served by Bruch’s membrane 
defects in the pathophysiology of CNV. In conclusion, 
Fig. 3 Comparison between indocyanine green angiography and 
optical coherence tomographic angiography for visualizing type 1 
neovascularization. Areas of type 1 NV (arrow) may be difficult to dis‑
cern on ICGA (a) due to hyperfluorescent staining of angioid streaks 
(arrowheads) within areas of NV. In contrast, type 1 NV demonstrates 
a characteristic tangled morphology appearance on OCTA (b) that is 
easily appreciated. Inset on ICGA corresponds to the region of interest 
on OCTA image. Note the projection artifact of retinal vessels on the 
OCTA image.
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multimodal imaging in combination with OCTA pro-
vides us with an excellent tool for the early detection and 
monitoring of AS related CNV. Those tools may enable 
improved visual outcomes for the management of CNV 
secondary to AS that often occurs in relatively young 
patient population with PXE.
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